Archemix Corp., of Cambridge, Mass., appointed Page Bouchard senior vice president of preclinical drug discovery and development.

Australian Cancer Technology Ltd., of Sydney, Australia, appointed Brett Heading and Alastair Hood nonexecutive directors.

California's state controller, Steve Westly, appointed Philip Pizzo, the dean of Stanford University's Medical School, to the Independent Citizen's Oversight Committee that will govern the California Institute for Regenerative Medicine established by Proposition 71.

Chiron Corp., of Emeryville, Calif., appointed Jack Goldstein chief operating officer and Anne Hill vice president of human resources.

Cougar Biotechnology Inc., of Los Angeles, appointed Gloria Lee vice president of clinical research and development.

Dendreon Corp., of Seattle, appointed James Caggiano vice president of sales and marketing.

Genentech Inc., of South San Francisco, appointed David Ebersman chief financial officer. He will replace Lou Lavigne when Lavigne retires in March. Pat Yang will replace Ebersman as leader of the company's product operations organization. Genentech also appointed Markus Gemuend vice president of manufacturing collaborations and contract manufacturing, and Timothy Moore vice president of corporate engineering.

Hana Biosciences Inc., of South San Francisco, appointed Russell Skibsted vice president and chief financial officer.

InterMune Inc., of Brisbane, Calif., appointed Cynthia Robinson senior vice president of the therapeutic area teams.

Invitrogen Corp., of Carlsbad, Calif., appointed Norman Russell vice president and general manager of its functional genomics strategic business unit.

IO Informatics, of Emeryville, Calif., elected Blaine Bowman and Richard Freyberg to its board.

Lexicon Genetics Inc., of The Woodlands, Texas, elected Frank Palantoni to its board.

Lifecore Biomedical Inc., of Chaska, Minn., appointed Luther Griffith to its board, and Kipling Thacker vice president of new business development.

Liska Biometry, of Candia, N.H., appointed Brian Metcalfe vice president of sales and marketing.

LogiMedix, of Weston, Fla., appointed Gregory Dupuis vice president of corporate development and sales, and Richard Butler vice president of operations.

Nuvios Inc., of Cambridge, Mass., appointed Christopher Glass to its scientific advisory board.

Oragenics Inc., of Alachua, Fla., appointed James Sharpe vice president of business development.

Predicant Biosciences, of South San Francisco, appointed Richard Bastiani to its board.

The Prostate Cancer Foundation in Los Angeles appointed Craig Dionne executive vice president of research and therapeutics.

Serono SA, of Geneva, appointed Stuart Grant chief financial officer.

Spectrum Pharmaceuticals Inc., of Irvine, Calif., appointed Kolli Prasad director of R&D, biologics, and Paul Vilk vice president of regulatory affairs.

StemCells Inc., of Palo Alto, Calif., appointed Judi Lum chief financial officer and vice president of finance.

Thomas, McNerney & Partners LLC in San Francisco appointed Pratik Shah venture partner.

Transkaryotic Therapies Inc., of Cambridge, Mass., promoted Neil Kirby to senior vice president of strategic product development; Paul Martha to senior vice president and chief medical officer; Gregory Perry to senior vice president and chief financial officer; Linda Pettingell to senior vice president of human resources and corporate services; and Suzanne Bruhn to vice president of global regulatory affairs.

Vivus Inc., of Mountain View, Calif., appointed Timothy Morris to serve as the company's principal financial officer and principal accounting officer.